Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9161 - 9168 of 12089 results
Update: Judge Scheindlin Grants Summary Judgment Against Class Member
September 2, 2015| Blog| Viewpoint
One Size Fits All? The Case for Unified Employment Policies for Multi-State Employers
September 2, 2015| Blog| Viewpoint
EB-5 Update: Expansion of Issuer Liability for Crowdfunding
September 2, 2015| Blog| Viewpoint
Northwestern Football Players Denied the Right to Unionize by NLRB; What’s Next?
September 1, 2015| Blog| Viewpoint
Expansion of Issuer Liability for Crowdfunding: What Might this Mean for the EB-5 Industry
September 1, 2015| Blog| Viewpoint
H-1B Alternatives Series: Flexibility in Foreign Trade and Treaty Visas
September 1, 2015| Blog| Viewpoint
SEC Steps Up Its Pursuit of Claims Involving the EB-5 Immigrant Investor Program
September 1, 2015| Blog| Viewpoint
Just How Scary is the SEC? “Fear” Not Sufficient Grounds to Duck Administrative Subpoena
September 1, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|